ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

NCI High School Summer Program Called Successful

October 19, 1990

Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs

March 22, 2002

In Congress: HHS Hasn’t Identified Another Source For NIH Increase If Tobacco Bill Not Passed: Shalala

March 6, 1998

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

April 28, 1995

Weekly Paclitaxel Better Than Every Three Weeks

June 25, 2004

ACS Offers New Grants to Physicians

September 7, 1984